FDA Approves New Catheter For Treatment Of Atrial Fibrillation

Share it with your friends Like

Thanks! Share it with your friends!

Close

The FDA has granted marketing approval for the Thermocool Smarttouch ablation catheter for use in patients with drug-resistant paroxysmal atrial fibrillation (AF), sustained monomorphic ischemic ventricular tachycardia and Type I atrial flutter. The

Comments

Write a comment

*